Pilot study finds cytokine differences between anti-NMDAR and viral encephalitis

This was a retrospective cohort pilot study analyzing blood cytokine profiles in 45 hospitalized patients: 15 with anti-NMDAR encephalitis, 15 with viral encephalitis, and 15 controls with non-inflammatory central nervous system diseases. The study compared these groups but did not report a specific intervention or exposure. The main findings were significant alterations in CSF/serum albumin ratio (QAlb), IL-4, and IL-17A levels across the groups. The markers exhibited diagnostic potential for differentiating anti-NMDAR encephalitis from viral encephalitis. In the anti-NMDAR encephalitis group, IL-17A and QAlb levels were positively correlated with hospital stay duration and modified Rankin Scale (mRS) score at admission, though the specific P value and effect sizes were not reported. Safety and tolerability data were not reported. Key limitations include its nature as a small-sample exploratory pilot study and its retrospective design, which limits causal inference. The funding and conflicts of interest were not reported. For practice, this study identifies preliminary trends and potential biomarkers, but the findings are not yet ready for clinical application due to the small scale and lack of quantified effect measures.